|
1
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ruggieri P, Mavrogenis AF and Mercuri M:
Quality of life following limb-salvage surgery for bone sarcomas.
Expert Rev Pharmacoecon Outcomes Res. 11:59–73. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Latronico MV, Catalucci D and Condorelli
G: MicroRNA and cardiac pathologies. Physiol Genomics. 34:239–242.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li Y and Kowdley KV: MicroRNAs in common
human diseases. Genomics Proteomics Bioinformatics. 10:246–253.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim VN: MicroRNA biogenesis: Coordinated
cropping and dicing. Nat Rev Mol Cell Biol. 6:376–385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Seitz H, Youngson N, Lin SP, Dalbert S,
Paulsen M, Bachellerie JP, Ferguson-Smith AC and Cavaillé J:
Imprinted microRNA genes transcribed antisense to a reciprocally
imprinted retrotransposon-like gene. Nat Genet. 34:261–262. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ying SY, Chang DC and Lin SL: The microRNA
(miRNA): Overview of the RNA genes that modulate gene function. Mol
Biotechnol. 38:257–268. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:pp. 2257–2261.
2006; View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Iwaya T, Yokobori T, Nishida N, Kogo R,
Sudo T, Tanaka F, Shibata K, Sawada G, Takahashi Y, Ishibashi M, et
al: Downregulation of miR-144 is associated with colorectal cancer
progression via activation of mTOR signaling pathway.
Carcinogenesis. 33:2391–2397. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kalimutho M, Del Vecchio Blanco G, Di
Cecilia S, Sileri P, Cretella M, Pallone F, Federici G and
Bernardini S: Differential expression of miR-144* as a novel
fecal-based diagnostic marker for colorectal cancer. J
Gastroenterol. 46:1391–1402. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo Y, Ying L, Tian Y, Yang P, Zhu Y, Wang
Z, Qiu F and Lin J: miR-144 downregulation increases bladder cancer
cell proliferation by targeting EZH2 and regulating Wnt signaling.
FEBS J. 280:4531–4538. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang X, Wang X, Zhu H, Zhu C, Wang Y, Pu
WT, Jegga AG and Fan GC: Synergistic effects of the GATA-4-mediated
miR-144/451 cluster in protection against simulated
ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell
Cardiol. 49:841–850. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang F, Huang XY, Yan DS, Zhou X and Yang
DY: MicroRNA-144 over-expression induced myocytes apoptosis.
Zhonghua Xin Xue Guan Bing Za Zhi. 39:353–357. 2011.(In Chinese).
PubMed/NCBI
|
|
15
|
Yu M, Liu Y, Zhang B, Shi Y, Cui L and
Zhao X: Inhibiting microRNA-144 abates oxidative stress and reduces
apoptosis in hearts of streptozotocin-induced diabetic mice.
Cardiovasc Pathol. 24:375–381. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pietenpol JA and Stewart ZA: Cell cycle
checkpoint signaling: Cell cycle arrest versus apoptosis.
Toxicology. 181–182. 1–481. 2002.PubMed/NCBI
|
|
18
|
Bologna-Molina R, Mosqueda-Taylor A,
Molina-Frechero N, Mori-Estevez AD and Sánchez-Acuña G: Comparison
of the value of PCNA and Ki-67 as markers of cell proliferation in
ameloblastic tumors. Med Oral Patol Oral Cir Bucal. 18:e174–e179.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Juríková M, Danihel Ľ, Polák Š and Varga
I: Ki67, PCNA, and MCM proteins: Markers of proliferation in the
diagnosis of breast cancer. Acta Histochem. 118:544–552. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Castilla C, McDonough P, Tumer G, Lambert
PC and Lambert WC: Sometimes it takes darkness to see the light:
Pitfalls in the interpretation of cell proliferation markers (Ki-67
and PCNA). Skinmed. 10:90–92. 2012.PubMed/NCBI
|
|
21
|
Geissler EK, Schlitt HJ and Thomas G:
mTOR, cancer and transplantation. Am J Transplant. 8:2212–2218.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sabatini DM: mTOR and cancer: Insights
into a complex relationship. Nat Rev Cancer. 6:729–734. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Altuvia Y, Landgraf P, Lithwick G, Elefant
N, Pfeffer S, Aravin A, Brownstein MJ, Tuschl T and Margalit H:
Clustering and conservation patterns of human microRNAs. Nucleic
Acids Res. 33:2697–2706. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen K and Rajewsky N: Deep conservation
of microRNA-target relationships and 3′UTR motifs in vertebrates,
flies, and nematodes. Cold Spring Harb Symp Quant Biol. 71:149–156.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Acunzo M, Romano G, Wernicke D and Croce
CM: MicroRNA and cancer-a brief overview. Adv Biol Regul. 57:1–9.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tong F, Cao P, Yin Y, Xia S, Lai R and Liu
S: MicroRNAs in gastric cancer: From benchtop to bedside. Dig Dis
Sci. 59:24–30. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Serpico D, Molino L and Di Cosimo S:
microRNAs in breast cancer development and treatment. Cancer Treat
Rev. 40:595–604. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang W, Peng B, Wang D, Ma X, Jiang D,
Zhao J and Yu L: Human tumor microRNA signatures derived from
large-scale oligonucleotide microarray datasets. Int J Cancer.
129:1624–1634. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang P, Fu T, Wang X and Zhu W: Primary,
study of miRNA expression patterns in laryngeal carcinoma by
microarray. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi.
24:535–538. 2010.(In Chinese). PubMed/NCBI
|
|
31
|
Tian Y, Tian Y, Luo X, Zhou T, Huang Z,
Liu Y, Qiu Y, Hou B, Sun D, Deng H, et al: Identification and
characterization of microRNAs related to salt stress in broccoli,
using high-throughput sequencing and bioinformatics analysis. BMC
Plant Biol. 14:2262014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rossing M, Borup R, Henao R, Winther O,
Vikesaa J, Niazi O, Godballe C, Krogdahl A, Glud M, Hjort-Sørensen
C, et al: Down-regulation of microRNAs controlling tumourigenic
factors in follicular thyroid carcinoma. J Mol Endocrinol.
48:11–23. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guled M, Lahti L, Lindholm PM, Salmenkivi
K, Bagwan I, Nicholson AG and Knuutila S: CDKN2A, NF2, and JUN are
dysregulated among other genes by miRNAs in malignant
mesothelioma-A miRNA microarray analysis. Genes Chromosomes Cancer.
48:615–623. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cao T, Li H, Hu Y, Ma D and Cai X: miR-144
suppresses the proliferation and metastasis of hepatocellular
carcinoma by targeting E2F3. Tumour Biol. 35:10759–10764. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zha W, Cao L, Shen Y and Huang M: Roles of
Mir-144-ZFX pathway in growth regulation of non-small-cell lung
cancer. PLoS One. 8:e741752013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao M, Huang J, Gui K, Xiong M, Cai G, Xu
J, Wang K, Liu D, Zhang X and Yin W: The downregulation of miR-144
is associated with the growth and invasion of osteosarcoma cells
through the regulation of TAGLN expression. Int J Mol Med.
34:1565–1572. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang W, Zhou X and Wei M: MicroRNA-144
suppresses osteosarcoma growth and metastasis by targeting ROCK1
and ROCK2. Oncotarget. 6:10297–10308. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xue J, Niu YF, Huang J, Peng G, Wang LX,
Yang YH and Li YQ: miR-141 suppresses the growth and metastasis of
HCC cells by targeting E2F3. Tumour Biol. 35:12103–12107. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang H, Rudge DG, Koos JD, Vaidialingam B,
Yang HJ and Pavletich NP: mTOR kinase structure, mechanism and
regulation. Nature. 497:217–223. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pene F, Claessens YE, Muller O, Viguié F,
Mayeux P, Dreyfus F, Lacombe C and Bouscary D: Role of the
phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in
the proliferation and apoptosis in multiple myeloma. Oncogene.
21:6587–6597. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Foster KG and Fingar DC: Mammalian target
of rapamycin (mTOR): Conducting the cellular signaling symphony. J
Biol Chem. 285:14071–14077. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang E, Feng X, Liu F, Zhang P, Liang J
and Tang X: Roles of PI3K/Akt and c-Jun signaling pathways in human
papillomavirus type 16 oncoprotein-induced HIF-1α, VEGF, and IL-8
expression and in vitro angiogenesis in non-small cell lung cancer
cells. PLoS One. 9:e1034402014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang W, Zhu J, Efferson CL, Ware C,
Tammam J, Angagaw M, Laskey J, Bettano KA, Kasibhatla S, Reilly JF,
et al: Inhibition of tumor growth progression by antiandrogens and
mTOR inhibitor in a Pten-deficient mouse model of prostate cancer.
Cancer Res. 69:7466–7472. 2009. View Article : Google Scholar : PubMed/NCBI
|
